Tranexamic acid
Tranexamic acid is a medicine that reduces bleeding by blocking the breakdown of blood clots. This atlas meets it in two separate roles, kept on separate pages: to treat heavy bleeding after birth that has started, and to try to prevent bleeding after birth. The two uses have different evidence.
- Drug
- In this atlas
Overview
Technical summary
Drug, level substance. RxCUI 10691 (RxNav name tranexamic acid, term type IN) read 2026-10-14. Mechanism (WOMAN introduction): it inhibits the enzymatic breakdown of fibrinogen and fibrin by plasmin. Uses kept apart: treatment of postpartum haemorrhage (the WOMAN trial and 2025 global Recommendation 27, on the existing treatment record) and prevention (WOMAN-2 and 2025 global Recommendations 14 and 15, on the prevention record). WOMAN-2 and the NCT03475342 registry record name the drug as the trial intervention. No clinical claim sits on this page.
About this drug
- Level
- Substance
- Mechanism
- Inhibits the enzymatic breakdown of fibrinogen and fibrin by plasmin (WOMAN introduction).
Claims and evidence
No claims are published for this drug yet.
Record details
- Record id
maternal:tranexamic-acid- Content hash
ca917e3acdb0f72b21d66f5628ed02886b64dfbcc8cf5f571fe186574d0c1106